Trial Profile
A phase 2, randomised, double-blind, placebo-controlled, crossover study to evaluate the effects of a topical pentosan polysulphate sodium (PPS) formulation in subjects with seasonal allergic rhinitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Jun 2017
Price :
$35
*
At a glance
- Drugs Pentosan polysulfate (Primary)
- Indications Seasonal allergic rhinitis
- Focus Therapeutic Use
- Sponsors Paradigm Pharmaceuticals
- 09 Jun 2017 Status changed from recruiting to completed.
- 15 Dec 2016 New trial record